Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TERADYNE, INCTER · Entity 181 | Director | March 15, 2024 | March 19, 2024 |
| VARIAN MEDICAL SYSTEMS INCVAR · Entity 140252 | Director | February 10, 2020 | February 12, 2020 |
| Varex Imaging CorpVREX · Entity 5135 | Director | February 12, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TERADYNE, INC
Report date March 15, 2024 · Filed March 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,729 |
Reported balance
After 2024-03-15 transaction · row 1
1 source rowRow 1 · 2024-03-15 · Other · Acquired 69 · Balance 62,729 F1: Represents deferred stock units ("DSUs") issued to the Reporting Person in accordance with his election to receive dividends paid on DSUs in the form of additional DSUs in lieu of cash. Such acquisition is exempt under Exchange Act Rule 16b-3(d). DSUs are settled one-for-one in Common Stock generally within ninety days of the date as of which a non-employee director no longer serves in such capacity. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units ("DSUs") issued to the Reporting Person in accordance with his election to receive dividends paid on DSUs in the form of additional DSUs in lieu of cash. Such acquisition is exempt under Exchange Act Rule 16b-3(d). DSUs are settled one-for-one in Common Stock generally within ninety days of the date as of which a non-employee director no longer serves in such capacity.
VARIAN MEDICAL SYSTEMS INC
Report date February 10, 2020 · Filed February 12, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,928 |
Reported balance
After 2020-02-10 transaction · row 1
1 source rowRow 1 · 2020-02-10 · Exercise / conversion · Acquired 1,990 · Balance 9,928 F1: Each deferred stock unit represents the right to receive one share of VAR common stock. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-02-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-10 · Exercise / conversion · Disposed 1,990 · Balance 0 F1: Each deferred stock unit represents the right to receive one share of VAR common stock. F2: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 32,125 |
Reported balance
Holding disclosure · report date 2020-02-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 32,125 |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of VAR common stock.
F2: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control.
Varex Imaging Corp
Report date February 12, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,331 |
Reported balance
After 2026-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 12,331 · Balance 12,331 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2018 Filed May 10, 2018 21:10 UTC | TERADYNE, INC TER · Entity 181 | GrantRestricted Stock Units · Derivative | 4,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-017092 · form4.xml · derivative · entry 3 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,849 Underlying: Common Stock · 4,849 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents the right to receive one share of Teradyne, Inc. common stock. F3 · derivative.exercise_date: These RSU's were issued under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan, are time-based, and will vest in full on the earlier of May 8, 2019 or the date the 2019 Annual Meeting of Shareholders is held. F3 · derivative.expiration_date: These RSU's were issued under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan, are time-based, and will vest in full on the earlier of May 8, 2019 or the date the 2019 Annual Meeting of Shareholders is held. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:10 UTC | TERADYNE, INC TER · Entity 181 | Exercise / conversionRestricted Stock Units · Derivative | 4,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-017092 · form4.xml · derivative · entry 2 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,931 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents the right to receive one share of Teradyne, Inc. common stock. F2 · derivative.exercise_date: These RSU's were issued under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan, are time-based, and will vest in full on the earlier of May 9, 2018 or the date the 2018 Annual Meeting of Shareholders is held. F2 · derivative.expiration_date: These RSU's were issued under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan, are time-based, and will vest in full on the earlier of May 9, 2018 or the date the 2018 Annual Meeting of Shareholders is held. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:10 UTC | TERADYNE, INC TER · Entity 181 | Exercise / conversionCommon Stock | 4,931 | $36.09 | $177,959.79 |
DisclosureSEC source: 0001127602-18-017092 · form4.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 21:09 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-006219 · form4.xml · derivative · entry 3 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,374 Underlying: Common Stock · 1,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 13, 2015. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 13, 2015. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 21:09 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-006219 · form4.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2018 Filed Feb 12, 2018 20:09 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005267 · form4.xml · derivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441 Underlying: Common Stock · 1,441 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 18:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 2,308 | $111.99 | $258,464.84 |
DisclosureSEC source: 0001127602-18-000784 · form4.xml · nonDerivative · entry 2 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 65,800 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 2,308 shares were sold in multiple transactions executed on the same day at prices ranging from $111.65 to $112.48. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 18:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 7,692 | $111.31 | $856,176.52 |
DisclosureSEC source: 0001127602-18-000784 · form4.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 68,108 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 7,692 shares were sold in multiple transactions executed on the same day at prices ranging from $110.62 to $111.59. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 13,600 | $103.39 | $1,406,038.72 |
DisclosureSEC source: 0001127602-17-021244 · form4.xml · nonDerivative · entry 2 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 75,800 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 13,600 shares were sold in multiple transactions executed on the same day at prices ranging from $102.91 to $103.72. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 19:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 2,400 | $102.29 | $245,506.80 |
DisclosureSEC source: 0001127602-17-021244 · form4.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 89,400 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 2,400 shares were sold in multiple transactions executed on the same day at prices ranging from $101.80 to $102.72. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:07 UTC | TERADYNE, INC TER · Entity 181 | GrantRestricted Stock Units · Derivative | 4,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-017790 · form4.xml · derivative · entry 3 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,931 Underlying: Common Stock · 4,931 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents the right to receive one share of Teradyne, Inc. common stock. F4 · derivative.exercise_date: These RSU's were issued under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan, are time-based, and will vest in full on the earlier of May 9, 2018 or the date the 2018 Annual Meeting of Shareholders is held. F4 · derivative.expiration_date: These RSU's were issued under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan, are time-based, and will vest in full on the earlier of May 9, 2018 or the date the 2018 Annual Meeting of Shareholders is held. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:07 UTC | TERADYNE, INC TER · Entity 181 | Exercise / conversionPhantom Stock Units · Derivative | 9,235 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-17-017790 · form4.xml · derivative · entry 2 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,138 Underlying: Common Stock · 9,235 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: At the election of the reporting person, upon vesting of the RSU's, the shares were converted into Phantom Stock Units (PSU's) pursuant to the Teradyne, Inc. Deferral Plan for Non-Employee Directors (as restated on May 25, 2006). The PSU's are to be settled 1 for 1 in the Issuer's common stock generally within ninety (90) days of the date the non-employee director no longer serves as such. F2 · price: At the election of the reporting person, upon vesting of the RSU's, the shares were converted into Phantom Stock Units (PSU's) pursuant to the Teradyne, Inc. Deferral Plan for Non-Employee Directors (as restated on May 25, 2006). The PSU's are to be settled 1 for 1 in the Issuer's common stock generally within ninety (90) days of the date the non-employee director no longer serves as such. F2 · derivative.exercise_date: At the election of the reporting person, upon vesting of the RSU's, the shares were converted into Phantom Stock Units (PSU's) pursuant to the Teradyne, Inc. Deferral Plan for Non-Employee Directors (as restated on May 25, 2006). The PSU's are to be settled 1 for 1 in the Issuer's common stock generally within ninety (90) days of the date the non-employee director no longer serves as such. F2 · derivative.expiration_date: At the election of the reporting person, upon vesting of the RSU's, the shares were converted into Phantom Stock Units (PSU's) pursuant to the Teradyne, Inc. Deferral Plan for Non-Employee Directors (as restated on May 25, 2006). The PSU's are to be settled 1 for 1 in the Issuer's common stock generally within ninety (90) days of the date the non-employee director no longer serves as such. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:07 UTC | TERADYNE, INC TER · Entity 181 | Exercise / conversionRestricted Stock Units · Derivative | 9,235 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-017790 · form4.xml · derivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,235 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Indicates conversion upon vesting of 100% of the time-based Restricted Stock Units (RSU's) granted on May 10, 2016 under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan. F2 · price: At the election of the reporting person, upon vesting of the RSU's, the shares were converted into Phantom Stock Units (PSU's) pursuant to the Teradyne, Inc. Deferral Plan for Non-Employee Directors (as restated on May 25, 2006). The PSU's are to be settled 1 for 1 in the Issuer's common stock generally within ninety (90) days of the date the non-employee director no longer serves as such. F1 · derivative.exercise_date: Indicates conversion upon vesting of 100% of the time-based Restricted Stock Units (RSU's) granted on May 10, 2016 under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan. F1 · derivative.expiration_date: Indicates conversion upon vesting of 100% of the time-based Restricted Stock Units (RSU's) granted on May 10, 2016 under the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 17:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007776 · form4.xml · derivative · entry 3 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,326 Underlying: Common Stock · 2,161 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 17:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007776 · form4.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:14 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantDeferred Stock Units · Derivative | 1,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005643 · form4.xml · derivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,487 Underlying: Common Stock · 1,990 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. F3 · balance_after: Includes deferred stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Deferred stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 21:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 3,100 | $90.55 | $280,690.74 |
DisclosureSEC source: 0001127602-16-065789 · form4.xml · nonDerivative · entry 2 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 91,800 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 3,100 shares were sold in multiple transactions executed on the same day at prices ranging from $90.19 to $90.79. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 21:55 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 900 | $89.56 | $80,604.99 |
DisclosureSEC source: 0001127602-16-065789 · form4.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 94,900 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 900 shares were sold in multiple transactions executed on the same day at prices ranging from $89.05 to $90.04. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| September 26, 2014 Filed Mar 13, 2023 22:05 UTC | TERADYNE, INC TER · Entity 181 | SaleCommon Stock | 10,321 | $19.45 | $200,743.45 |
DisclosureSEC source: 0000904454-23-000233 · edgar.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,883 F1 · balance_after: The share ownership reported in Column 5 is stated as of the date of this filing and not as of the date of the transaction reported herein. It was recently discovered by the Reporting Person that due to a clerical oversight this transaction had not previously been reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.